You are here: Industry Insights > Lyrica

News List

Complete response letter sent for two generic products europeanpharmaceuticalreview
August 19, 2019
A complete response letter (CRL) has been sent to Dr Reddy’s for two generic products.
FDA grants approvals for generic Lyrica expresspharma
July 25, 2019
The US Food and Drug Administration (US FDA) has approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia.
FDA Approves First Generics of Lyrica americanpharmaceuticalreview
July 24, 2019
The U.S. Food and Drug Administration (FDA) has approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy ...
FDA approves nine generics for Lyrica drug europeanpharmaceuticalreview
July 24, 2019
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
FDA Approves First Generics of Lyrica drugs
July 23, 2019
The U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica(pregabalin) for the management of neuropathic pain associated ...
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users drugs
June 14, 2019
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users.
Some research may be encouraging ineffective prescriptions, says new study eurekalert
November 27, 2018
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments....
The future of Pfizer’s $5bn Lyrica brand is in jeopardy pharmaceutical-technology
November 22, 2018
Lyrica (pregabalin) has been Pfizer’s flagship blockbuster brand for many years due to the fact that it has been approved in multiple indications. It has also been the highest-selling neurology brand for several years.
Pfizer loses Lyrica patent case in UK Supreme Court pharmaceutical-technology
November 16, 2018
The UK Supreme Court has ruled against Pfizer in a long running legal case involving a second medical use patent for its Lyrica (pregabalin) drug.
Pfizer's Epilepsy medication Lyrica gives positive results in pediatric study biospectrumasia
May 21, 2018
LYRICA is currently approved for various indications in more than 130 countries and regions globally

Previous page 1 2 Next page